Xencor Inc. | Key People and Executives
Bassil I. Dahiyat
President, Chief Executive Officer & Director
Richard J. Ranieri
Independent Director
Kevin Charles Gorman
Independent Director
Yujiro S. Hata
Independent Director
Alan B. Montgomery
Independent Director
Kurt A. Gustafson
Independent Director
Bassil I. Dahiyat
President, Chief Executive Officer & Director
John J. Kuch
CFO, Secretary & Principal Accounting Officer
Paul A. Foster
Chief Medical Officer & Senior Vice President
John R. Desjarlais
Chief Scientific Officer & Senior VP-Research
Raphael Clynes
Vice President-Translational Biology
Wayne Saville
Vice President-Clinical Oncology
Mark W. Lotz
Vice President-Regulatory Affairs
Richard J. Ranieri
Independent Director
Kevin Charles Gorman
Independent Director
Yujiro S. Hata
Independent Director
Alan Bruce Montgomery
Independent Director
Kurt A. Gustafson
Independent Director
| Address |
111 West Lemon Avenue
Monrovia California 91016
United States
|
|
Employees
|
- |
| Website |
http://www.xencor.com |
| Updated |
07/08/2019 |
| Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. |
